CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $527.57 | $63K | 44,713 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −342 | $529.80 | $181K | 44,371 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −703 | $530.91 | $373K | 43,668 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −671 | $531.65 | $357K | 42,997 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −364 | $533.15 | $194K | 42,633 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −920 | $533.93 | $491K | 41,713 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −830 | $535.12 | $444K | 40,883 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −370 | $536.16 | $198K | 40,513 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 88,000 | ||
| 2026-03-20 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-03-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $520.34 | $21K | 49,973 |
| 2026-03-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −520 | $521.69 | $271K | 49,453 |
| 2026-03-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,538 | $523.28 | $805K | 47,915 |
| 2026-03-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,749 | $524.18 | $1.4M | 45,166 |
| 2026-03-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,815 | $525.02 | $953K | 43,351 |
| 2026-03-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −660 | $526.06 | $347K | 42,691 |
| 2026-03-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −993 | $527.08 | $523K | 41,698 |
| 2026-03-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −865 | $527.99 | $457K | 40,833 |
| 2026-03-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $529.08 | $169K | 40,513 |
| 2026-03-20 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 97,500 |
Page 143 of 171 · 3,408 trades